Share:
Understanding dealmaking trends offers a powerful lens into the emerging mechanisms, modalities, and technologies that are poised to deliver strong returns on investment.
That’s where we come in.
Leveraging our unique, comprehensive dealmaking data and expert analysis we’ll uncover upcoming mechanisms and technologies which just might be the next ADC or GLP-1.
Join our webinar to gain exclusive insights that will help you stay ahead in a rapidly evolving landscape.
This webinar explores how recent licensing and acquisition trends reveal pharma’s growing interest in modalities like targeted protein degradation (TPD), TL1A, and novel RNA platforms such as saRNA and circRNA.
Attendees will learn how to leverage Evaluate Pharma’s deal, pipeline, and forecast data to rank mechanisms and technologies by commercial potential, helping BD&L teams spot future blockbusters early.
